Literature DB >> 12019118

Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.

Emmanuel Roilides1, Caron A Lyman, Joanna Filioti, Onome Akpogheneta, Tin Sein, Cristina Gil Lamaignere, Ruta Petraitiene, Thomas J Walsh.   

Abstract

Deoxycholate amphotericin B (DAMB) and amphotericin B lipid complex (ABLC) additively augmented the fungicidal activity of pulmonary alveolar macrophages against the conidia of Aspergillus fumigatus. DAMB, ABLC, and liposomal amphotericin B similarly displayed additive effects with polymorphonuclear leukocytes in damaging the hyphal elements of A. fumigatus.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12019118      PMCID： PMC127213          DOI： 10.1128/AAC.46.6.1974-1976.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Enhancement of macrophage superoxide anion production by amphotericin B.

Authors:  E Wilson; L Thorson; D P Speert
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 3.  Mode of action of clinically important antifungal drugs.

Authors:  D Kerridge
Journal:  Adv Microb Physiol       Date:  1986       Impact factor: 3.517

Review 4.  Invasive pulmonary aspergillosis in patients with neoplastic diseases.

Authors:  T J Walsh
Journal:  Semin Respir Infect       Date:  1990-06

5.  Effects of antifungal agents on the function of human neutrophils in vitro.

Authors:  E Roilides; T J Walsh; M Rubin; D Venzon; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions.

Authors:  K Yasui; M Masuda; T Matsuoka; M Yamazaki; A Komiyama; T Akabane; K Murata
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 7.  Immunomodulating activity of antifungal drugs.

Authors:  H Yamaguchi; S Abe; Y Tokuda
Journal:  Ann N Y Acad Sci       Date:  1993-06-23       Impact factor: 5.691

8.  Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

9.  Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity.

Authors:  W R Perkins; S R Minchey; L T Boni; C E Swenson; M C Popescu; R F Pasternack; A S Janoff
Journal:  Biochim Biophys Acta       Date:  1992-06-30

10.  Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors.

Authors:  C Pannuti; R Gingrich; M A Pfaller; C Kao; R P Wenzel
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860
View more
  12 in total

1.  Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Massimo Offidani; Bruno Martino; Giorgina Specchia; Domenico Pastore; Marta Stanzani; Chiara Cattaneo; Rosa Fanci; Cecilia Caramatti; Fausto Rossini; Mario Luppi; Leonardo Potenza; Felicetto Ferrara; Maria Enza Mitra; Rafaela Maria Fadda; Rosangela Invernizzi; Teresa Aloisi; Marco Picardi; Alessandro Bonini; Adriana Vacca; Anna Chierichini; Lorella Melillo; Chiara de Waure; Luana Fianchi; Marta Riva; Giuseppe Leone; Franco Aversa; Annamaria Nosari
Journal:  Haematologica       Date:  2009-10-22       Impact factor: 9.941

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Heat-treated Fungizone retains amphotericin B antifungal activity without renal toxicity in rats infected with Aspergillus fumigatus.

Authors:  Olena Sivak; Karen Bartlett; Kishor M Wasan
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

4.  The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.

Authors:  William W Hope; Vidmantas Petraitis; Ruta Petraitiene; Tamarra Aghamolla; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 5.  Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Authors:  Marit D Moen; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.

Authors:  J Dotis; M Simitsopoulou; M Dalakiouridou; T Konstantinou; A Taparkou; F Kanakoudi-Tsakalidou; T J Walsh; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

7.  Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.

Authors:  Ronen Ben-Ami; Nathaniel D Albert; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

8.  It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug.

Authors:  Ana C Mesa-Arango; Liliana Scorzoni; Oscar Zaragoza
Journal:  Front Microbiol       Date:  2012-08-08       Impact factor: 5.640

9.  Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals.

Authors:  Roberta Gaziano; Silvia Bozza; Silvia Bellocchio; Katia Perruccio; Claudia Montagnoli; Lucia Pitzurra; Giovanni Salvatori; Rita De Santis; Paolo Carminati; Alberto Mantovani; Luigina Romani
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

10.  In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes.

Authors:  Susanne Perkhofer; Cornelia Speth; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Mycopathologia       Date:  2007-04-26       Impact factor: 3.785
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.